Bank of New York Mellon’s Repros Therapeutics Inc. RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-36,983
| Closed | -$24K | – | 4495 |
|
|
2017
Q4 | $24K | Buy |
36,983
+15,210
| +70% | +$9.87K | ﹤0.01% | 4278 |
|
|
2017
Q3 | $7K | Hold |
21,773
| – | – | ﹤0.01% | 4251 |
|
|
2017
Q2 | $10K | Sell |
21,773
-673
| -3% | -$309 | ﹤0.01% | 4268 |
|
|
2017
Q1 | $27K | Buy |
22,446
+673
| +3% | +$810 | ﹤0.01% | 4202 |
|
|
2016
Q4 | $29K | Sell |
21,773
-1,403
| -6% | -$1.87K | ﹤0.01% | 4184 |
|
|
2016
Q3 | $48K | Sell |
23,176
-4,023
| -15% | -$8.33K | ﹤0.01% | 4142 |
|
|
2016
Q2 | $44K | Hold |
27,199
| – | – | ﹤0.01% | 4194 |
|
|
2016
Q1 | $26K | Hold |
27,199
| – | – | ﹤0.01% | 4156 |
|
|
2015
Q4 | $33K | Sell |
27,199
-26,811
| -50% | -$32.5K | ﹤0.01% | 4204 |
|
|
2015
Q3 | $401K | Buy |
54,010
+6,093
| +13% | +$45.2K | ﹤0.01% | 3643 |
|
|
2015
Q2 | $342K | Sell |
47,917
-97,214
| -67% | -$694K | ﹤0.01% | 3746 |
|
|
2015
Q1 | $1.25M | Buy |
145,131
+11,553
| +9% | +$99.2K | ﹤0.01% | 3172 |
|
|
2014
Q4 | $1.33M | Buy |
133,578
+7,373
| +6% | +$73.5K | ﹤0.01% | 3128 |
|
|
2014
Q3 | $1.25M | Buy |
126,205
+9,409
| +8% | +$93.1K | ﹤0.01% | 3163 |
|
|
2014
Q2 | $2.02M | Sell |
116,796
-6,168
| -5% | -$107K | ﹤0.01% | 2894 |
|
|
2014
Q1 | $2.18M | Buy |
122,964
+1,250
| +1% | +$22.2K | ﹤0.01% | 2821 |
|
|
2013
Q4 | $2.23M | Sell |
121,714
-16,761
| -12% | -$307K | ﹤0.01% | 2818 |
|
|
2013
Q3 | $3.71M | Buy |
138,475
+38,271
| +38% | +$1.03M | ﹤0.01% | 2424 |
|
|
2013
Q2 | $1.85M | Buy |
+100,204
| New | +$1.85M | ﹤0.01% | 2833 |
|